TP53 mutations/deletions are involved in CLL transformation into a more aggressive disease (i.e. Richter syndrome) and may reside in dormant clones in the very early stages of the disease [57]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.